Oncol Rep 45: [Related article:] 77, 2021; DOI:
10.3892/or.2021.8028
Following the publication of the above article, the
authors have requested a change in the authorship on the paper, and
the revised list of authors is presented above; essentially, the
ninth intended author, Giuseppe Salvo (G.S.), was inadverently
omitted from the author list. G.S. contributed towards the T design
and the preparation of the tagged ScFv. Therefore, the revised
authors’ names and affiliations, as they should have been presented
in the original version of this paper, are as follows:
ELISA TREMANTE1, LEONARDO
SIBILIO2,7, FABIO CENTOLA2,8, NADINE
KNUTTI3,9, GERD HOLZAPFEL4, ISABELLA
MANNI5, MATTEO ALLEGRETTI1, PAOLO
LOMBARDI6, GIUSEPPE SALVO2,10,
LOREDANA CECCHETELLI2, KARLHEINZ FRIEDRICH3,
JOACHIM BERTRAM4 and PATRIZIO GIACOMINI1
1Oncogenomics and Epigenetics, IRCCS
Regina Elena National Cancer Institute, Rome; 2Ibi
Lorenzini, Aprilia, Italy; 3University Hospital Jena,
Institute of Biochemistry II, Jena; 4IBA GmbH,
Göttingen, Germany; 5SAFU, IRCCS Regina Elena National
Cancer Institute, Rome; 6NaxosPharma, Novate Milanese,
Milan, Italy
Correspondence to: Dr Patrizio Giacomini.
Oncogenomics and Epigenetics, IRCCS Regina Elena National Cancer
Institute, Via Elio Chianesi 53, 00144 Rome, Italy, E-mail:
patrizio.giacomini@ifo.gov.it
Present address: 7Menarini
Biotech, Pomezia, Rome, Italy
Present address: 8Merck Serono
Spa, Global Analytical Department, Guidonia Montecelio, Rome,
Italy
Present address: 9University
Hospital Jena Institute for Clinical Chemistry and Laboratory
Diagnostics, Jena, Germany
Present address: 10External
Quality Assurance (ExM), MSD Italia S.r.l., Via Vitorchiano 151,
00189 Rome, Italy
Furthermore, the Authors contributions section
should be amended to read as follows:
Authors' contributions
ET and MA tested the TOOLBOX concept and performed
the flow cytometry experiments. LS, FC, GS and LC designed and
prepared the tagged ScFv. NK and KF designed and prepared the
GFP promoter-reporter construct. GH and JB designed and
manufactured Strep-Tactins. ET and IM performed animal studies. PL
designed and manufactured NAX and NAXT compounds. PG conceptualized
TOOLBOX and wrote the manuscript with the contribution of all
authors. All authors have approved the final version of the
manuscript.
All the authors agree with the inclusion of Giuseppe
Salvo as an author on this paper, and are grateful to the Editor
for allowing them the opportunity to publish this Corrigendum.
Furthermore, they apologize to the readership of the Journal for
any inconvenience caused.
